IDYA Competitors & Alternatives
Compare Ideaya Biosciences Inc with similar stocks in the same industry
Biotechnology
IDYA
Main Stock$28.98
Tradestie Score
59
Market Cap
$2.40B
Revenue Growth
0.6%
Analyst Upside
+78.4%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$39.72
|
$3.03B | - | 57 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$52.10
|
$3.02B | - | 58 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$59.56
|
$3.01B | - | 55 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$24.35
|
$2.89B | - | 63 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$33.62
|
$2.85B | - | 63 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.36
|
$2.56B | 18.1 | 55 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$29.03
|
$2.44B | - | 55 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$61.95
|
$2.42B | - | 59 | Compare |
More IDYA Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry